Analysen von Michael Leuchten

06.12.16 Bayer buy UBS AG
06.12.16 Novo Nordisk buy UBS AG
12.05.16 Sanofi overweight Barclays Capital
10.05.16 Merck Equal weight Barclays Capital
04.05.16 GSK overweight Barclays Capital
02.05.16 Novo Nordisk overweight Barclays Capital
27.04.16 Bayer Equal weight Barclays Capital
22.04.16 Novartis Equal weight Barclays Capital
14.04.16 Novartis Underweight Barclays Capital
10.03.16 Merck Equal weight Barclays Capital
19.02.16 Bayer Underweight Barclays Capital
19.02.16 Merck Equal weight Barclays Capital
09.02.16 Merck Equal weight Barclays Capital
04.02.16 Novo Nordisk overweight Barclays Capital
03.02.16 Sanofi Equal weight Barclays Capital
28.01.16 Novartis Underweight Barclays Capital
15.01.16 Roche overweight Barclays Capital
15.01.16 Novartis Underweight Barclays Capital
08.01.16 Novo Nordisk overweight Barclays Capital
05.01.16 Bayer Underweight Barclays Capital
05.01.16 Merck Equal weight Barclays Capital
11.12.15 Merck Equal weight Barclays Capital
24.11.15 Sanofi Equal weight Barclays Capital
03.11.15 Merck Equal weight Barclays Capital
28.10.15 Novartis Equal weight Barclays Capital
07.08.15 Merck Equal weight Barclays Capital
28.07.15 Roche overweight Barclays Capital
22.07.15 Novartis Equal weight Barclays Capital
10.07.15 Bayer Underweight Barclays Capital
04.03.15 Merck Equal weight Barclays Capital
27.02.15 Bayer Underweight Barclays Capital
13.02.15 Bayer Underweight Barclays Capital
12.02.15 Roche overweight Barclays Capital
06.02.15 Sanofi Equal weight Barclays Capital
29.10.14 Sanofi Equal weight Barclays Capital
12.08.14 Merck Underweight Barclays Capital
31.07.14 Bayer Equal weight Barclays Capital
16.05.14 Merck Underweight Barclays Capital
14.05.14 Merck Underweight Barclays Capital
08.05.14 Bayer Equal weight Barclays Capital
26.07.10 Actelion overweight Barclays Capital